SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001341004-16-001597
Filing Date
2016-08-05
Accepted
2016-08-05 17:02:45
Documents
2
Group Members
JLL ASSOCIATES V (PATHEON) L.P.JLL PARTNERS FUND V (NEW PATHEON) L.P.JLL PARTNERS FUND VI (PATHEON) L.P.JLL PATHEON CO-INVESTMENT FUND L.P.JLL PATHEON FF II LLCJLL/DELTA PATHEON GP LTD.JLL/DELTA PATHEON HOLDINGS L.P.PATHEON HOLDCO COOPERATIEF U.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 326337
2 EXHIBIT 1 - JOINT FILING AGREEMENT ex-1.htm EX-99 53052
  Complete submission text file 0001341004-16-001597.txt   381390
Mailing Address HERENGRACHT 483 AMSTERDAM P7 1017BT
Business Address HERENGRACHT 483 AMSTERDAM P7 1017BT 31 (20) 622-3243
Patheon N.V. (Subject) CIK: 0001643848 (see all company filings)

IRS No.: 981153534 | State of Incorp.: P7 | Fiscal Year End: 1031
Type: SC 13D | Act: 34 | File No.: 005-89586 | Film No.: 161811889
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JLL PARTNERS 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address C/O JLL PARTNERS 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017 (212) 286-8600
JLL Associates G.P. V (Patheon), Ltd. (Filed by) CIK: 0001679434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D